Back to Search
MARY PUGSLEY, MD
MD
Internal Medicine Physician
NPI: 1710965645Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD15737(OR)
Research & Publications (20)
The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetes.
PMID 16416656·Proc West Pharmacol Soc·2005
6-review
The opioid receptor independent actions of kappa receptor agonists in the cardiovascular system.
PMID 15320754·Curr Pharm Des·2004
6-review
An overview of some pharmacological methods used in safety pharmacology studies.
PMID 15633602·Proc West Pharmacol Soc·2004
6-review
Spiradoline, a kappa opioid receptor agonist, produces tonic- and use-dependent block of sodium channels expressed in Xenopus oocytes.
PMID 11483291·Gen Pharmacol·2000
4-observational
U-50,488H, a kappa opioid receptor agonist, is a more potent blocker of cardiac sodium channels than lidocaine.
PMID 11056955·Proc West Pharmacol Soc·2000
4-observational
Perception of validity of clinical and preclinical methods for assessment of torsades de pointes liability.
PMID 18590766·Pharmacol Ther·2008
7-preclinical
Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines.
PMID 18493243·Br J Pharmacol·2008
7-preclinical
Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid.
PMID 18469556·Blood Coagul Fibrinolysis·2008
8-other
Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor.
PMID 17572702·Br J Pharmacol·2007
7-preclinical
A review of the structural and functional features of olmesartan medoxomil, an angiotensin receptor blocker.
PMID 16220064·J Cardiovasc Pharmacol·2005
6-review
Inhibitors of the complement system currently in development for cardiovascular disease.
PMID 12668890·Cardiovasc Toxicol·2003
6-review
Commercial development considerations for biotechnology-derived therapeutics.
PMID 12668886·Cardiovasc Toxicol·2003
6-review
Sodium channel blocking and antiarrhythmic actions of the novel arylpiperazine rsd992.
PMID 12208117·Pharmacol Res·2002
7-preclinical
The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system.
PMID 11916541·Pharmacol Ther·2002
6-review
Protamine is a low molecular weight polycationic amine that produces actions on cardiac muscle.
PMID 12427488·Life Sci·2002
7-preclinical
The use of a novel retractor system and small animal surgery tray in a rat coronary artery occlusion model.
PMID 11793989·Proc West Pharmacol Soc·2001
7-preclinical
Cardiovascular and antiarrhythmic properties of protamine in rats.
PMID 11793988·Proc West Pharmacol Soc·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 920 COUNTRY CLUB RD, SUITE 200A
EUGENE, OR 97401 - Phone
- (541) 342-2134
Quick Facts
- NPI
- 1710965645
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile